Print

QR Pharma to Present at the 44th Winter Conference on Brain Research  
1/19/2011 9:10:48 AM

(BUSINESS WIRE)--QR Pharma, Inc., a developer of novel compounds to treat Alzheimer’s disease (AD), announced today that the company will be presenting a poster on the mechanism of action and clinical data of its lead compound Posiphen® and that Dr. Maria L. Maccecchini, CEO of QR, will be a symposium speaker at the 44th Winter Conference on Brain Research, January 22-27, 2011 in Keystone, Colorado.
//-->